CD47 and pancreatic neoplasm: Therefore, we further evaluated the effects of HT combined with anti-CD47 antibody on mouse pancreatic cancer progression, and our findings indicated that HT enhanced the anti-tumor effect of anti-CD47 antibody in vivo.